Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit

Journal of Critical Care

Volumn 27, Issue 6, 2012, Pages 739.e1-739.e6

  Yeo, Chang Dong ^a   Kim, Jin Woo ^a   Kim, Seok Chan ^a   Kim, Young Kyoon ^a   Kim, Kwan Hyoung ^a   Kim, Hee Je ^a   Lee, Seok ^a   Rhee, Chin Kook ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hematologic malignancy; Intensive care unit; Prognosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVOR; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PH; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

EID: 84870702104     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.07.014     Document Type: Article

References (40)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002, 360(9340):1131-1135.
2. Brenner H., Gondos A., Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007, 25(22):3274-3280.
3. Sculier J.P., Markiewicz E. Medical cancer patients and intensive care. Anticancer Res 1991, 11(6):2171-2174.
4. Staudinger T., et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000, 28(5):1322-1328.
5. Geerse D.A., et al. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 2011, 22(1):57-61.
6. Cherif H., et al. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Support Care Cancer 2007, 15(12):1393-1398.
7. Ferra C., et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 2007, 85(3):195-202.
8. Park M.R., et al. Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit. J Crit Care 2011, 26(1):107.e1-107.e6.
9. Yang T.M., et al. Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensive care units. J Formos Med Assoc 2007, 106(4):295-301.
10. Lamia B., et al. Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 2006, 32(10):1560-1568.
11. Kroschinsky F., et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 2002, 28(9):1294-1300.
12. Benoit D.D., et al. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003, 31(1):104-112.
13. Nishida K., Palalay M.P. Prognostic factors and utility of scoring systems in patients with hematological malignancies admitted to the intensive care unit and required a mechanical ventilator. Hawaii Med J 2008, 67(10):264-269.
14. Hampshire P.A., et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009, 13(4):R137.
15. Bird G.T., et al. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 2012, 108(3):452-459.
16. Rhee C.K., et al. Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies. Crit Care 2009, 13(6):R173.
17. Rubenfeld G.D., Crawford S.W. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 1996, 125(8):625-633.
18. Hosmer D.W., Taber S., Lemeshow S. The importance of assessing the fit of logistic regression models: a case study. Am J Public Health 1991, 81(12):1630-1635.
19. Vandijck D.M., et al. Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med 2010, 36(10):1744-1750.
20. Eom K.S., et al. Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia. Leuk Lymphoma 2011, 52(12):2321-2328.
21. Lee S.E., et al. Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities. Int J Hematol 2010, 92(2):342-350.
22. Eom K.S., et al. Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older. Eur J Haematol 2007, 79(5):398-404.
23. Eom K.S., et al. FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia. Med Oncol 2011, 28(Suppl. 1):S462-S470.
24. Kim H.J., et al. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 2009, 15(6):704-717.
25. Kim H.J., et al. Hematopoietic stem cell transplatation with using multinational unrelated donors for acute myeloneous leukemia. Korean J Hematol 2007, 42(2):98-105.
26. Kim H.J., et al. Haplotype mismatch transplantation using high-dose CD34+ cells with stratified new conditioning regimens in patients with acute myeloid leukemia. Korean J Hematol 2003, 38(4):221-227.
27. Bahammam A.S., et al. Outcome of patients with hematological malignancies admitted to the intensive care unit with life-threatening complications. Saudi Med J 2005, 26(2):246-250.
28. Depuydt P.O., et al. Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest 2004, 126(4):1299-1306.
29. Maynadie M., et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica 2011, 96(1):55-61.
30. Ribera J.M. Advances in acute lymphoblastic leukemia in adults. Curr Opin Oncol 2011, 23(6):692-699.
31. Estey E.H. Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012, 87(1):89-99.
32. Peters S.G., Meadows J.A., Gracey D.R. Outcome of respiratory failure in hematologic malignancy. Chest 1988, 94(1):99-102.
33. Massion P.B., et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002, 30(10):2260-2270.
34. Taccone F.S., et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009, 13(1):R15.
35. Azoulay E., et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002, 30(4):781-786.
36. Owczuk R., et al. Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer 2005, 13(5):332-338.
37. Villa F., et al. Etiology of respiratory failure is related to mortality in critically ill patients affected by a hematological malignancy: a retrospective study. Minerva Anestesiol 2010, 76(1):7-12.
38. Sculier J.P., et al. Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med 2000, 28(8):2786-2792.
39. Groeger J.S., et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1998, 16(2):761-770.
40. Lemeshow S., Klar J., Teres D. Outcome prediction for individual intensive care patients: useful, misused, or abused?. Intensive Care Med 1995, 21(9):770-776.